Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of the Effectiveness and Safety of Topiramate in the Treatment of Moderate to Severe Binge-Eating Disorder Associated With Obesity
This study has been completed.
Study NCT00210808   Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received: September 13, 2005   Last Updated: April 23, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Obesity
Binge-Eating Disorder
Additional conditions recognized in this trial
Bulimia
Bulimia Nervosa
Disease
Eating Disorders
More general conditions related to this trial
Body Weight
Hyperphagia
Mental Disorders
Nutrition Disorders
Overnutrition
Overweight
Pathologic Processes
Signs and Symptoms
Signs and Symptoms, Digestive
Interventions listed in this trial
topiramate
More general drug interventions related to this trial
Anti-Obesity Agents
Anticonvulsants
Central Nervous System Agents
Neuroprotective Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Johnson &Johnson Pharmaceutical Research &Development, L.L.C.
Ortho-McNeil Neurologics, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services